Clinical Trial 44682

Tustin, CA 92780


Summary:

A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled study to evaluate the efficacy and safety of AK002 in Adult and Adolescent patients with Active Eosinophilic Esophagitis (EoE)


Qualified Participants Must:

• Age 12 to 80 Years Old
• Have GERD or Acid Reflux two or more times per week
• Cough or Choke while eating
• and/or have a diagnosis of Eosinophilic Esophagitis (EoE)


Qualified Participants May Receive:

Up to $3700.00


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.